KeyNeurotek Pharmaceuticals
Magdeburg
About KeyNeurotek Pharmaceuticals
KeyNeurotek is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2009)
- Website: keyneurotek.de
- Phone: +49 (0) 3 91.6 11 72 20
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/keyneurotek-pharmaceuticals-2122292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.